1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Deafness Global Clinical Trials Review, H2, 2015

Deafness Global Clinical Trials Review, H2, 2015

  • August 2015
  • -
  • Global Data
  • -
  • 73 pages

Deafness Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Deafness Global Clinical Trials Review, H2, 2015" provides an overview of Deafness clinical trials scenario. This report provides top line data relating to the clinical trials on Deafness. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Deafness Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Deafness 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Deafness to Ear Nose Throat Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Deafness to Ear Nose Throat Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Deafness 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Deafness Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
ProjectPharm s.r.o. 32
Clinical Trial Overview of ProjectPharm s.r.o. 32
Nordmark Arzneimittel GmbH and Co. KG 33
Clinical Trial Overview of Nordmark Arzneimittel GmbH and Co. KG 33
Leading Clinical Research, s.r.o. 34
Clinical Trial Overview of Leading Clinical Research, s.r.o. 34
CogniFit, Ltd. 35
Clinical Trial Overview of CogniFit, Ltd. 35
ClinSupport GmbH 36
Clinical Trial Overview of ClinSupport GmbH 36
Clinical Trial Overview of Top Institutes / Government 37
Assistance Publique - Hopitaux de Paris 37
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 37
Capital District Health Authority, Canada 38
Clinical Trial Overview of Capital District Health Authority, Canada 38
Carmel Medical Center 39
Clinical Trial Overview of Carmel Medical Center 39
Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico 40
Clinical Trial Overview of Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico 40
Islamic Azad University of Tabriz 41
Clinical Trial Overview of Islamic Azad University of Tabriz 41
Massachusetts Eye and Ear Infirmary 42
Clinical Trial Overview of Massachusetts Eye and Ear Infirmary 42
Neurological Foundation of New Zealand 43
Clinical Trial Overview of Neurological Foundation of New Zealand 43
Southwest Hospital, China 44
Clinical Trial Overview of Southwest Hospital, China 44
Suita Municipal Hospital 45
Clinical Trial Overview of Suita Municipal Hospital 45
The Sheba Medical Center 46
Clinical Trial Overview of The Sheba Medical Center 46
Five Key Clinical Profiles 47
Appendix 70
Abbreviations 70
Definitions 70
Research Methodology 71
Secondary Research 71
About GlobalData 72
Contact Us 72
Disclaimer 72
Source 73

List of Tables
Deafness Therapeutics, Global, Clinical Trials by Region, 2015* 7
Deafness Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Deafness Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Deafness Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Deafness Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Deafness Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Deafness Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Deafness Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Deafness to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 15
Deafness Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Deafness Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Deafness to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015* 18
Deafness Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Deafness Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Deafness Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Deafness Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Deafness Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Deafness Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Deafness Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Deafness Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Deafness Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Deafness Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Deafness Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Deafness Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Deafness Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Deafness Therapeutics Clinical Trials Market, Global, Clinical Trials by ProjectPharm s.r.o., 2015* 32
Deafness Therapeutics Clinical Trials Market, Global, Clinical Trials by Nordmark Arzneimittel GmbH and Co. KG, 2015* 33
Deafness Therapeutics Clinical Trials Market, Global, Clinical Trials by Leading Clinical Research, s.r.o., 2015* 34
Deafness Therapeutics Clinical Trials Market, Global, Clinical Trials by CogniFit, Ltd., 2015* 35
Deafness Therapeutics Clinical Trials Market, Global, Clinical Trials by ClinSupport GmbH, 2015* 36
Deafness Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 37
Deafness Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2015* 38
Deafness Therapeutics Clinical Trials Market, Global, Clinical Trials by Carmel Medical Center, 2015* 39
Deafness Therapeutics Clinical Trials Market, Global, Clinical Trials by Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, 2015* 40
Deafness Therapeutics Clinical Trials Market, Global, Clinical Trials by Islamic Azad University of Tabriz, 2015* 41
Deafness Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts Eye and Ear Infirmary, 2015* 42
Deafness Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurological Foundation of New Zealand, 2015* 43
Deafness Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Hospital, China, 2015* 44
Deafness Therapeutics Clinical Trials Market, Global, Clinical Trials by Suita Municipal Hospital, 2015* 45
Deafness Therapeutics Clinical Trials Market, Global, Clinical Trials by The Sheba Medical Center, 2015* 46

List of Figures
Deafness Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Deafness Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Deafness Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Deafness Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Deafness Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Deafness Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Deafness Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Deafness to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 15
Deafness Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Deafness Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Deafness to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015* 18
Deafness Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Deafness Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Deafness Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Deafness Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Deafness Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Deafness Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Deafness Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Deafness Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Deafness Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Deafness Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Deafness Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 71

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.